is there a mind of our top stories this hour us pharmaceutical company, modena says early results show its covert. 19 vaccine is 94.5 percent effective in preventing the virus fellow drug maker, pfizer, an ounce. it's vaccine was 90 percent effective. u.s. president elect joe biden has laid out his plans to revive the u.s. economy, but stressed that coronavirus must 1st be brought under control. he warned lives are at risk if don't trump continues to resist cooperation with the transition team . the u.s. national security adviser says he's likely to see the blockade on qatar result within 70 days. brian also said a 1st step would be for saudi arabia and bahrain to fully reopen their airspace to qatar a aircraft. former world bank official francisco has been chosen by peru's congress to be the new interim president. the said national leader in a week or so gusty from a centrist political party, assumes the presidency ahead of elections scheduled for april. former interim leader manuma reno resigned on sunday 5 days after he replaced martin the skara who was impeached and scary to all co

the modena job between 2025 to $37.00, they require 2 doses. so meaning the total doses could go up to 40 in the 1st case . and as high as $74.00 for the vaccine, the course of the sport that could be vaccine is currently estimated to be around $26.00 for the 2 doses though the final costs are due to be confirmed next week. as you can see, the astra zeneca one trumps all of them at $8.00 for the treatment, while the race is now on to register these vaccines astra zeneca said it would be seeking, emergency use emergency listing from the world health organization. and russia have said they've already begun the process for destroying their sputnik vaccine several days ago. despite the good news with multiple vaccines emerging, it's still too early to be entirely up to mystic about seeing the back of covert 19 . this is not the time for complacency. while we continue to receive encouraging news about 19 vaccines and remain cautiously optimistic about the potential for the new tools to start to arrive in the coming mines. right now, we are extremely

drug from modena reportage just on the 95 percent effectiveness for its vaccine. we are confident that if, if be.

while the estimated price of the pfizer vaccine is around $19.00, the modena job between $25.00 to $37.00, those prices go up to over $40.00. and as high as $74.00, respectively for the total treatment of the cost of the sport, mcvie vaccine is estimated at $26.00 per treatment. the final costs are yet to be announced. the astra zeneca job would not only be easier to manufacture and store, but the cost for both those whose could be as low as $8.00 for the race is now on to register these vaccines astra zeneca states that it would seek emergency use listing from the world health organization with russia saying they've already begun the sputnik registration process despite the good news, it's too early to say. we've seen the back of the pandemic, even with these promising trial results, doos is not the time for complacency. while we continue to receive encouraging news about 19 vaccines and remain cautiously optimistic about the potential for a new tools to start to arrive in the coming months. right now, we are extremely concerned by the surging cases we are seeing in some countries, parti

modena, wasn't selling vaccines overseas. i was keeping it within the united states. this is disputed then when the european union vote on 160000000 doses. now the u.k. has bought 5000000 sense. but as far as you're seeing it, these vaccines are being equally shed out amongst the world's most medias populations. so i don't, i don't actually, you know, at this point, you know, we have 3 vaccines that have been effective for, i think, 2 months, highly effective. you know, all of them are over 90 percent africa's. their efficacy is over 90 percent. they appear to be safe again with 2 months worth of data. so are these, the vaccines that will be effective for 6 months and 12 months? we hope so, but do we know that? no, we don't. i mean, when you're where we're thinking about these axioms, it's very exciting. it's an important proof of concept for our navy accedes. and for vaccines for covert 19. and it holds out hope that a vaccine solution will be available, actually fairly shortly. for some, you know, it's there not very many doses yet. there nothing like a 16000000000

modena, the 2nd candidate, the chance of getting approval. you will remember, pfizer announced last week that its vaccine was 90 percent effective in late stage trials. all very promising news as the infections continue to climb with the u.s. alone. now with those over 11000000 confirmed cases, the highest in the worlds so very pleased to bring in the office in new york who is a professor of epidemiology and medicine at columbia university. we've spoken to a number of times doctor about this. how excited are you about the news you've heard from madonna's today? very excited. indeed. they're having this news that today regarding them with their no vaccine and about a week ago on the highs effects seen both of which show more and then early do you know more than 90 percent because see this is really very, very encouraging and being said for the world over are can you give us any more detail from, from, from what you've heard from? one of the key issues, if you like, with the finds a vaccine, was how it had to be stored at very, very cold temper

these results come after another us drug from modena reportage just on the 95 percent effectiveness for its vaccine. we are confident that if we continue to close to call over it, that it could could happen that we get an order was until mid of the stand and could start to, to provide the 1st millions of doses of experienced to the region get an approval on october, how did you, castro has more on the speed of the trials in the us. the fact that the 3rd stage clinical trials wrapped up so quickly here for advisor is because the participants had more exposure to cohabit than initially the timeline had anticipated. that is because of how big of a peak the u.s. is experiencing at this moment with 11400000 people having already been infected. now the way that this study was conducted is that they took 44000, people slip them into groups, half of them got the vaccine. the other had did not among the group that did not get the vaccine. well, there were 162 cases of cove it 3 people have been killed in protests in uganda after a presidential opposition candidate was arrested. the pop star turn

pharmaceutical company, modena says, early results show its covert 900 vaccine is 94.5 percent effective in preventing the virus fellow drug maker fison announced its vaccine was 90 percent effective. both plant regulators for emergency approval within weeks. it's really important milestone in the fight against the pending because it demonstrates that our very senior morning 1273 is able to prevent cope with 90 disease including severe disease. and it's really just a milestone though. we have a lot of work ahead of us knowing the vaccine is going to be effective is great news, but we still need to complete the regulatory process, which involves completing the study, generally more to follow it safe. and then of course,, we need to get busy manufacturing. u.s., president elect joe biden has laid out his plan to revive the u.s. economy. but stress that coronavirus must 1st be brought under control. he warned, lives are at risk if donald trump continues to resist cooperating with the transition team. the u.s. national security adviser says he'd like to see the blockade on castle resolved wi

today we learn of modena vaccine at 94.5% why would you take 90% if you have 94.5% we should be hearingall other major players. i hate to think where the stocks may be with the pfizer update and moderna. even though these vaccines have been developed, we have one major hurdle we got to start thinking of how to get hundreds of millions of viles to americans and people overse overseas the federal government vaccine program plans to distribute it to the states. state governments have to figure it out themselves and federalism have not had the best record fighting this virus. you have to keep it refrigerated and especially in the case of pfizer vaccine which it will go bad. getting it where it needs to go would be a whole production. where the government drops the ball, private enterprise is stepping up. tonight i want to take you to the terrific companies that are apart of the vaccine all are intriguing for investors we were talking about giants like united parcel and fedex and some pharmacies and super markets that i kind of like to suggest that everything be good here let's start with up

we've had the fines and modena vaccines really some very positive results earlier this week. and now some encouraging news from the oxford vaccine. tell us more about their findings. yes, so oxford has collaborated with a pharmaceutical company astra zeneca, and they've just released their phase 2 trial results. that's based on, a volunteer group of 560 taken from the u.k., brazil, south africa. this is not their phase trick. 3 trial results. those a-g. in a few more weeks now be a lot, much larger sampling group. but so far, initial results are showing that the vaccine is generating a strong immune response in adults, in the sixty's and seventy's age group, a crucial age group, because vaccines typically don't work so well in older people. because as we get older, our immune systems deteriorate with age. this vaccine is different from those developed by and pfizer, by, on tech because those used a new technology known as m r n a. this is a more traditional one. it's used a wee conversion of the common cold virus found in chimpanzees. it's been modified so it can't grow in hu